Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; 1:50
| Perrigue P, Silva M, Warden C, Feng N, Reid M, Mota D, et al. The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines. Mol Cancer Res. 2015;13:636-50 pubmed publisher
|
| Nunes Santos C, Kuehn H, Boast B, Hwang S, Kuhns D, Stoddard J, et al. Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling. Nat Commun. 2023;14:3708 pubmed publisher
|
| Salameh J, Kumar S, Rivera Cruz C, FIGUEIREDO M. A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications. Bioengineering (Basel). 2022;9: pubmed publisher
|
| Csomós I, Nagy P, Filep C, Rebenku I, Nizsalóczki E, Kovacs T, et al. Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells. Int J Mol Sci. 2021;22: pubmed publisher
|
| Alasady M, Terry A, Pierce A, Cavalier M, Blaha C, Adipietro K, et al. The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling. PLoS ONE. 2021;16:e0256238 pubmed publisher
|
| Van Zeebroeck L, Arroyo Hornero R, Côrte Real B, Hamad I, Meissner T, Kleinewietfeld M. Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol. 2021;12:655122 pubmed publisher
|
| Wu J, Weisshaar N, Hotz Wagenblatt A, Madi A, Ma S, Mieg A, et al. Skeletal muscle antagonizes antiviral CD8+ T cell exhaustion. Sci Adv. 2020;6:eaba3458 pubmed publisher
|
| Zhang G, Iwase H, Wang L, Yamamoto T, Jagdale A, Ayares D, et al. Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?. Am J Transplant. 2020;20:999-1013 pubmed publisher
|
| Saga R, Hasegawa K, Murata K, Chiba M, Nakamura T, Okumura K, et al. Regulation of radiosensitivity by 4-methylumbelliferone via the suppression of interleukin-1 in fibrosarcoma cells. Oncol Lett. 2019;17:3555-3561 pubmed publisher
|
| Eriksson E, Milenova I, Wenthe J, Moreno R, Alemany R, Loskog A. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. J Immunol. 2019;: pubmed publisher
|
| Eriksson E, Moreno R, Milenova I, Liljenfeldt L, Dieterich L, Christiansson L, et al. Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment. Gene Ther. 2017;24:92-103 pubmed publisher
|
| Ferreira R, Freitag D, Cutler A, Howson J, Rainbow D, Smyth D, et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013;9:e1003444 pubmed publisher
|